IMCC:NASDAQ, IM Cannabis Corp.
IMCC stock overview
IM Cannabis Corp. (IMCC:NASDAQ) closed at $0.878 on October 23, 2026,
down 5.08% on the day.
The stock trades 98.6% below its 52-week high of $62.40
and 9.7% above its 52-week low of $0.800.
Over the past year, it lost 41.1%.
IM Cannabis Corp. is part of the Health Care sector.
Key figures
- Price
- $0.878
- Day change
- -5.08%
- Volume
- 69,948
- Average volume
- 2,763,756
- Market cap
- 1M+
- 52-week range
- $0.800 – $62.40
- 50-day average
- $2.42
- 200-day average
- $12.41
Price action over the past year
In 251 trading sessions since October 23, 2025, IMCC closed higher on 90 days (36%).
Its best day was September 18, 2026 (+143.10%) and its worst was September 23, 2026 (-29.71%).
The stock moved 10% or more in a single session 46 times.
It opened at least 5% above the previous day's high 7 times.
Recent signals
IMCC news
-
Sep 29, 2026:
IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
-
Sep 24, 2026:
IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares
-
Sep 23, 2026:
IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Sep 23, 2026:
IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares
-
Sep 23, 2026:
IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market
-
Sep 2, 2026:
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
-
Aug 27, 2026:
IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis
-
Aug 18, 2026:
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
About IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel, followed by Germany.
Similar stocks
Find more stocks like IMCC with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.